A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer. (Q33365305)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer. |
scientific article |
Statements
A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer (English)
Henry C Pitot
Grace K Dy
Alex A Adjei
Lorelei J Hanson
Charles Erlichman
Joel M Reid
Gary A Croghan
Laura M Bruzek
Sumithra Mandrekar
Alfred Furth
Shinta Cheng
Robert E Martell